These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15993351)

  • 1. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
    Costacou T; Lopes-Virella MF; Zgibor JC; Virella G; Otvos J; Walsh M; Orchard TJ
    J Diabetes Complications; 2005; 19(4):183-93. PubMed ID: 15993351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants and coronary artery disease among individuals with type 1 diabetes: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Costacou T; Zgibor JC; Evans RW; Tyurina YY; Kagan VE; Orchard TJ
    J Diabetes Complications; 2006; 20(6):387-94. PubMed ID: 17070445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetes.
    Natarajan A; Marshall SM; Kesteven PJ; McComb JM; Rutter MK
    Diabet Med; 2011 Oct; 28(10):1201-5. PubMed ID: 21480978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease.
    Winkelmann BR; Boehm BO; Nauck M; Kleist P; März W; Verho NK; Ranjith N; Kneissl G
    Curr Med Res Opin; 2001; 17(2):132-41. PubMed ID: 11759183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population.
    Thorand B; Baumert J; Chambless L; Meisinger C; Kolb H; Döring A; Löwel H; Koenig W;
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):398-405. PubMed ID: 16322530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower-extremity arterial calcification as a correlate of coronary artery calcification.
    Costacou T; Huskey ND; Edmundowicz D; Stolk R; Orchard TJ
    Metabolism; 2006 Dec; 55(12):1689-96. PubMed ID: 17142145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes.
    Wadwa RP; Kinney GL; Ogden L; Snell-Bergeon JK; Maahs DM; Cornell E; Tracy RP; Rewers M
    Int J Biochem Cell Biol; 2006; 38(5-6):996-1003. PubMed ID: 16271309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
    Glowinska B; Urban M; Peczynska J; Florys B
    Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study).
    Ruef J; März W; Winkelmann BR
    Scand Cardiovasc J; 2006 Oct; 40(5):274-9. PubMed ID: 17012137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the metabolic syndrome with early coronary disease in families with frequent myocardial infarction.
    Reinhard W; Holmer SR; Fischer M; Gloeckner C; Hubauer U; Baessler A; Mayer B; Schunkert H; Riegger GA; Hengstenberg C
    Am J Cardiol; 2006 Apr; 97(7):964-7. PubMed ID: 16563895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 is associated with coronary artery calcium in Type 1 diabetes.
    Pratte KA; Barón AE; Ogden LG; Hassell KL; Rewers M; Hokanson JE
    J Diabetes Complications; 2009; 23(6):387-93. PubMed ID: 18768333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.
    Koga H; Sugiyama S; Kugiyama K; Watanabe K; Fukushima H; Tanaka T; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2005 May; 45(10):1622-30. PubMed ID: 15893178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2.
    Endler G; Exner M; Raith M; Marculescu R; Mannhalter C; Endler L; Wojta J; Huber K; Wagner OF
    Thromb Res; 2003; 112(1-2):47-50. PubMed ID: 15013273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
    Costacou T; Zgibor JC; Evans RW; Otvos J; Lopes-Virella MF; Tracy RP; Orchard TJ
    Diabetologia; 2005 Jan; 48(1):41-8. PubMed ID: 15616802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
    Zgibor JC; Piatt GA; Ruppert K; Orchard TJ; Roberts MS
    Diabetes Care; 2006 Aug; 29(8):1860-5. PubMed ID: 16873793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy?
    Bavbek N; Kargili A; Kaftan O; Karakurt F; Kosar A; Akcay A
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):391-7. PubMed ID: 17911190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
    Ndrepepa G; Kastrati A; Braun S; Koch W; Kölling K; Mehilli J; Schömig A
    Clin Chim Acta; 2006 Nov; 373(1-2):70-6. PubMed ID: 16814762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.